A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.

Clinical trial NCT00518011 · COMPLETED

Trial details

NCT number: NCT00518011
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer

Start date: 2007-08-01
Primary completion: 2009-02-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.